RHYTHM PHARMACEUTICALS, INC. (RYTM) Nonoperating Income (Expense) USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2024.
  • Rhythm Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$1.19 M, a 437% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$1.29 M, a 15.8% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $243 K.
  • Rhythm Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.96 M, a 102% decline from 2021.
  • Rhythm Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $100 M, a 3795% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$1.29 M -$1.19 M -$1.54 M -437% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $243 K -$168 K +$222 K +56.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $21 K $158 K +$1.75 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$1.73 M -$99 K -$194 K -204% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 -$1.54 M $352 K +$425 K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$1.96 M -$390 K -$524 K -391% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$1.44 M -$1.59 M -$1.73 M -1255% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $294 K $95 K +$74 K +352% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $220 K -$73 K -$100 M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $100 M $134 K -$42 K -23.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $100 M $138 K -$328 K -70.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $101 M $21 K -$780 K -97.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $102 M $100 M +$99 M +8716% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $2.58 M $176 K -$1.09 M -86.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $3.67 M $466 K -$638 K -57.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $4.31 M $801 K -$552 K -40.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $4.86 M $1.14 M -$410 K -26.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 $5.27 M $1.27 M -$376 K -22.9% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 $5.65 M $1.1 M -$454 K -29.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $6.1 M $1.35 M +$744 K +122% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 $5.36 M $1.55 M +$1 M +185% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $4.35 M $1.64 M +$1.19 M +264% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $3.16 M $1.56 M +$3.29 M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$127 K $609 K +$657 K Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$784 K $542 K +$513 K +1769% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$1.3 M $452 K +$443 K +4922% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$1.74 M -$1.73 M -$1.74 M -17400% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-08
Q2 2017 $0 -$48 K -$56 K -700% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-08
Q1 2017 $56 K $29 K +$23 K +383% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-08
Q4 2016 $33 K $9 K Oct 1, 2016 Dec 31, 2016 8-K 2018-11-09
Q3 2016 $10 K Jul 1, 2016 Sep 30, 2016 8-K 2018-11-09
Q2 2016 $8 K Apr 1, 2016 Jun 30, 2016 8-K 2018-11-09
Q1 2016 $6 K Jan 1, 2016 Mar 31, 2016 8-K 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.